Us Physicalrapy Stock Performance
| USPH Stock | USD 81.28 1.75 2.11% |
US Physicalrapy has a performance score of 7 on a scale of 0 to 100. The entity owns a Beta (Systematic Risk) of 0.89, which indicates possible diversification benefits within a given portfolio. US Physicalrapy returns are very sensitive to returns on the market. As the market goes up or down, US Physicalrapy is expected to follow. US Physicalrapy at this moment owns a risk of 2.01%. Please validate US Physicalrapy treynor ratio, and the relationship between the coefficient of variation and semi variance , to decide if US Physicalrapy will be following its current price history.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, US Physicalrapy may actually be approaching a critical reversion point that can send shares even higher in April 2026. ...more
Actual Historical Performance (%)
One Day Return 0.0844 | Five Day Return (0.18) | Year To Date Return 5.26 | Ten Year Return 64.71 | All Time Return 4.2 K |
Forward Dividend Yield 0.0218 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 1.81 | Dividend Date 2026-04-10 |
1 | U.S. Physical Therapy, Inc. Given Average Recommendation of Moderate Buy by Analysts | 12/10/2025 |
| US Physicalrapy dividend paid on 12th of December 2025 | 12/12/2025 |
2 | As U.S. Physical Therapy advances 6.4 percent this past week, investors may now be noticing the companys five-year earnings growth | 12/16/2025 |
3 | Assessing U.S. Physical Therapys Valuation After Sector Upgrade Sparks Renewed Investor Interest | 12/23/2025 |
4 | U.S. Physical Therapy Expands Nationwide Outpatient Care Network | 12/29/2025 |
5 | Why Are U.S. Physical Therapy Shares Soaring Today | 01/05/2026 |
6 | U.S. Physical Therapys Outperform Rating Reiterated at Barrington Research | 01/08/2026 |
7 | Acquisition by Swanson Regg E. of 1882 shares of US Physicalrapy subject to Rule 16b-3 | 02/04/2026 |
8 | Assessing U.S. Physical Therapys Valuation After Recent Share Price Momentum | 02/05/2026 |
9 | Exploring US Physical Therapys Earnings Expectations | 02/24/2026 |
| Begin Period Cash Flow | 41.4 M | |
| Total Cashflows From Investing Activities | -36.7 M |
US Physicalrapy Relative Risk vs. Return Landscape
If you would invest 7,541 in US Physicalrapy on December 3, 2025 and sell it today you would earn a total of 762.00 from holding US Physicalrapy or generate 10.1% return on investment over 90 days. US Physicalrapy is currently generating 0.1803% in daily expected returns and assumes 2.0112% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than USPH, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Physicalrapy Target Price Odds to finish over Current Price
The tendency of USPH Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 81.28 | 90 days | 81.28 | about 53.04 |
Based on a normal probability distribution, the odds of US Physicalrapy to move above the current price in 90 days from now is about 53.04 (This US Physicalrapy probability density function shows the probability of USPH Stock to fall within a particular range of prices over 90 days) .
US Physicalrapy Price Density |
| Price |
Predictive Modules for US Physicalrapy
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as US Physicalrapy. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.US Physicalrapy Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. US Physicalrapy is not an exception. The market had few large corrections towards the US Physicalrapy's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold US Physicalrapy, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of US Physicalrapy within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.17 | |
β | Beta against Dow Jones | 0.89 | |
σ | Overall volatility | 4.19 | |
Ir | Information ratio | 0.08 |
US Physicalrapy Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of US Physicalrapy for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for US Physicalrapy can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 97.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from benzinga.com: Exploring US Physical Therapys Earnings Expectations |
US Physicalrapy Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of USPH Stock often depends not only on the future outlook of the current and potential US Physicalrapy's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. US Physicalrapy's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.2 M | |
| Cash And Short Term Investments | 35.6 M |
US Physicalrapy Fundamentals Growth
USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.
| Return On Equity | 0.0759 | ||||
| Return On Asset | 0.0425 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.54 B | ||||
| Shares Outstanding | 15.2 M | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 2.50 X | ||||
| Price To Sales | 1.63 X | ||||
| Revenue | 780.99 M | ||||
| Gross Profit | 171.02 M | ||||
| EBITDA | 109.66 M | ||||
| Net Income | 58.01 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 425.74 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 31.50 X | ||||
| Cash Flow From Operations | 75.06 M | ||||
| Earnings Per Share | 2.37 X | ||||
| Market Capitalization | 1.26 B | ||||
| Total Asset | 1.2 B | ||||
| Retained Earnings | 227.22 M | ||||
| Working Capital | 21.3 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
About US Physicalrapy Performance
By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.04 | 0.04 | |
| Return On Capital Employed | 0.08 | 0.07 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.03 | 0.03 |
Things to note about US Physicalrapy performance evaluation
Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 97.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from benzinga.com: Exploring US Physical Therapys Earnings Expectations |
- Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
- Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |